Introduction: A Continent Under Pressure
At the 2026 MedTech Forum held in Stockholm, Sweden, from 11–13 May, the atmosphere was defined by a sobering recognition: the era of "business as usual" for the European medical technology sector has come to an end. Following the disruptive wake of the Covid-19 pandemic, the industry is now navigating a complex geopolitical landscape characterized by active conflict, supply chain instability, and the urgent need for structural resilience.
MedTech Europe CEO Oliver Bisazza opened the forum with a candid assessment of the current environment. Describing the industry as a vital strategic pillar of the European economy, he acknowledged that it is currently "surrounded by storms." For industry leaders, the past year has felt like a "washing machine of tariffs, supply chain bottlenecks, and geopolitical shocks." As Europe confronts the realities of a shifting global order, the mandate for the medical device sector is no longer just about growth—it is about endurance.
The Chronology of Crisis: From Pandemic to Geopolitical Volatility
The urgency surrounding the forum’s discussions was rooted in a series of cascading crises that have tested the limits of European healthcare.
- 2020–2022 (The Pandemic Catalyst): The onset of Covid-19 exposed deep vulnerabilities in Europe’s healthcare continuity. Fragmented government responses, characterized by competing national interests and poor transparency, led to severe shortages of personal protective equipment (PPE) and ventilators. Studies have since confirmed that these early failures fueled significant public distrust.
- 2022 (The Invasion of Ukraine): The Russian invasion of Ukraine fundamentally changed the security paradigm for European healthcare. It transformed the medical device sector from a commercial concern into a frontline strategic asset.
- 2026 (The Middle East Conflict): The escalation of the US-Israel conflict, which widened in February 2026, brought new, immediate threats to the supply chain. Iran’s subsequent decision to close the Strait of Hormuz—a critical maritime chokepoint—has sent shockwaves through international logistics, complicating the delivery of vital medical components and raw materials.
Supporting Data: The Scale of the Challenge
The data presented in Stockholm provided a stark picture of the challenges faced by healthcare providers and manufacturers.
In Ukraine, the human and infrastructural cost is staggering. Dmytro Gusiev, deputy head of mission at the Ukraine embassy in Sweden, reported that as of May 2026, over 2,600 healthcare facilities have been damaged or destroyed by Russian military actions. Despite this, the resilience of the Ukrainian system remains a marvel of wartime management:
- Operational Continuity: Over 1,500 facilities continue to provide full medical services.
- Adaptive Infrastructure: Approximately 200 facilities operate at partial capacity.
- Strategic Hardening: Ukraine has implemented nationwide use of voltage stabilizers to protect sensitive diagnostic and therapeutic equipment from power grid surges, alongside the deployment of generators and strategic fuel reserves to ensure a minimum of several days of autonomous operation.
These figures illustrate a transition from a civilian medical model to a "war-footing" model, where the survival of the equipment is as critical as the survival of the patient.
Official Responses and Strategic Shifts
The forum served as a platform for governments and industry leaders to outline new strategies for crisis preparedness. The consensus was clear: the fragmentation seen during the pandemic is a luxury Europe can no longer afford.
The Finnish and Swedish Models of Preparedness
Laura Rissanen, State Secretary to the Minister for Social Security in Finland, argued that for Europe to survive future crises, the health and defense sectors must merge their planning. "Finland does not have separate military hospitals," Rissanen explained, noting that the country is conducting intensive preparedness planning that integrates health and defense. For Finland, which shares a 1,300-kilometer border with Russia, military aggression is now viewed as an inherent "health threat."
Sweden is taking a similarly proactive stance. Michaela Hollis, State Secretary to the Swedish Minister for Health Care, highlighted the government’s shift toward robust, centralized stockpiling. Sweden is currently working on a national overview of medical devices, supported by improved product identification and a mapping of domestic production capacity. "Pandemic and natural disasters do not stop at national borders," Hollis noted, "and neither can our preparedness efforts." By entering into new agreements with regional authorities, Sweden aims to reduce its reliance on fragile global supply chains.
The Industry Perspective: Judicious Stockpiling
Industry representatives cautioned against the idea that "more is better" when it comes to stockpiling. Veronique Tordoff, Vice President and Head of Image Guided Therapy for Europe at Philips, emphasized that European nations must prioritize which devices are truly critical.
"We can’t stockpile everything at once," Tordoff stated. The strategy must be rationalized based on the nature of the crisis. During a pandemic, the requirement is for high-volume, low-complexity items like PPE; in a military conflict, the need shifts toward portable, high-technology diagnostic tools like patient monitors and portable ultrasound machines.
To manage this, companies like Philips are increasingly acting as strategic partners to governments. By managing, maintaining, and reconditioning stockpiled equipment—which has already seen deployment in both Ukraine and disaster zones like Türkiye—these firms provide the "right actors in the ecosystem" needed to ensure that equipment is not just stored, but ready for immediate, field-grade operation.
Implications for the Future of European Medtech
The implications of these discussions are profound. The European medtech sector is moving away from a globalized, just-in-time delivery model toward a more localized, security-conscious approach.
1. The Necessity of Cross-Sectoral Collaboration
The days of health ministries working in isolation from defense and transport ministries are over. Future resilience requires a "whole-of-government" approach where medical supply chains are treated with the same strategic priority as energy or defense infrastructure.
2. Rationalized Stockpiling Protocols
There is an urgent need for a pan-European consensus on what constitutes a "critical" medical device. Without standardized categorization and product identification across the EU, the current ad-hoc stockpiling efforts may prove insufficient in the face of a massive, multi-front crisis.
3. Economic Constraints and Sustainability
A significant tension remains: the constrained economic landscape in Europe has led to a degradation of some of the crisis-response measures implemented during the height of the Covid-19 pandemic. As government budgets tighten, the challenge will be to justify the cost of maintaining "idle" strategic reserves against the background of immediate fiscal demands.
4. Learning from the Frontline
The most profound takeaway from the 2026 MedTech Forum was the recognition that Ukraine’s experience is a blueprint. The rapid decision-making, the use of specialized vehicular fleets for medication delivery, and the creation of a tiered hospital network are not just temporary fixes—they are innovations in healthcare management that offer a template for broader European resilience.
Conclusion: A Proactive Future
As the MedTech Forum concluded, the mood was one of cautious determination. The "storm" surrounding the industry—whether in the form of maritime blockades in the Middle East or military aggression in Eastern Europe—is not expected to dissipate in the near term.
For the European medical technology ecosystem, the path forward is clear. By leveraging the lessons learned from the battlefield and the boardroom, and by fostering deeper cooperation between state actors and the private sector, Europe aims to replace the fragmented, reactive response of the past with a unified, resilient system. As the industry looks toward the next decade, the goal is not merely to survive the next crisis, but to ensure that the continuity of care remains a fixed, immovable pillar of European society, regardless of the global turmoil outside its borders.
About the Author
